Study designed to assess the safety of 3-month dual antiplatelet therapy.
Evolve Short DAPT: A prospective, multicenter, single-arm study designed to assess the safety of 3-month dual antiplatelet therapy (DAPT) in subjects at high risk for bleeding undergoing percutaneous intervention with the SYNERGY Stent System. Done only at SMC
Questions: Call Mary Soltau 303-703-2191 or Rebecca Wimmer 303-715-2275